Legislators
Bills
Statements
Lobbying
Travel
- Bills
- H.R.2026
H.R.2026: Pharmaceutical Information Exchange Act
About This Bill
- This bill was introduced in the 115th Congress
- This bill is primarily about health
- Introduced April 6, 2017
- Latest Major Action Jan. 17, 2018
Bill Sponsor
Bill Version
- Introduced in House - April 6, 2017
Bill Summary
Pharmaceutical Information Exchange Act This bill amends the Federal Food, Drug, and Cosmetic Act to allow information about a new investigational medication or the investigational use of a medication approved by the Food and Drug Administration to be provided to health care entities if the information is based on reliable scientific evidence.
(Source: Library of Congress)
What Lawmakers Are Saying About This Bill
Bill Actions
Date | Description |
---|---|
Jan. 17, 2018 |
Forwarded by Subcommittee to Full Committee (Amended) by the Yeas and Nays: 18 - 14 .
|
Jan. 17, 2018 |
Subcommittee Consideration and Mark-up Session Held.
|
April 7, 2017 |
Referred to the Subcommittee on Health.
|
April 6, 2017 |
Referred to the House Committee on Energy and Commerce.
|
April 6, 2017 |
Introduced in the House by Brett Guthrie (R-Ky.) |